Trials / Unknown
UnknownNCT00566176
Sole-Therapy Treatment of Atrial Fibrillation
Thoracoscopically-Assisted Epicardial Bilateral Pulmonary Vein Isolations Using the AtriCure Bipolar System and Exclusion of the Left Atrial Appendage for the Treatment of Atrial Fibrillation
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 25 (actual)
- Sponsor
- AtriCure, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
RESTORE SR II is a feasibility study on the minimally invasive use of the AtriCure Bipolar System for PV Isolation on a beating heart for the treatment of all types of atrial fibrillation in a sole therapy operation (not concomitant to another cardiac operation).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Surgical Ablation using the AtriCure Bipolar System | Surgical Ablation using the AtriCure Bipolar System |
Timeline
- Start date
- 2005-10-01
- Primary completion
- 2007-12-01
- Completion
- 2017-02-01
- First posted
- 2007-12-03
- Last updated
- 2013-02-05
Locations
5 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00566176. Inclusion in this directory is not an endorsement.